The HRT patches shortage UK has become a frequent concern for women going through menopause and their clinicians. Many patients report difficulty keeping transdermal patches in stock at local pharmacies and through online repeat services.
Below is a quick reference that captures where the shortages are most acute, typical wait times, alternative options, and what patients can do right now.
| Product Type | Current Availability UK | Typical Delay if Out of Stock | Common Alternatives |
|---|---|---|---|
| Oestradiol 50 mcg patches | High shortage in community pharmacies | 7–21 days for new supplies | Gel, tablets, lower-dose patches |
| Combined patches (oestradiol + norethisterone) | Very limited stock in some regions | 14–28 days or longer | Sequential oral regimens |
| Unbranded vs branded (Evorel, FemSeven) | Unbranded more stable, branded more intermittent | Variable by supplier | Switch to generic or different brand |
| Online repeat delivery services | Frequent backorders | 3–10 extra days for fulfilment | Pharmacy direct collection |
Understanding The UK Patch Supply Situation
Supply issues trace back to manufacturing constraints and shifts in prescription patterns after the pandemic. Many patients who had been stable on patches for years suddenly faced gaps when repeat prescriptions were processed in bulk by centralised pharmacies.
Wholesale distribution bottlenecks and the prioritisation of higher-volume medications created a mismatch between stock arriving at community pharmacies and patient demand. This explains why some regions report empty shelves while others have intermittent availability.
Current Availability By Region And Pharmacy Chain
Availability varies noticeably between NHS regions, with some CCGs placing restrictions or recommending step therapy before approving another patch brand. Large chains often follow centralised directives that can delay approvals for individual clinicians.
Independent and specialist menopause pharmacies typically have better insight into upcoming stock and can sometimes source products that high-street chains cannot. Calling ahead or using a dedicated menopause pharmacy can reduce the number of wasted trips.
Prescribing And Referral Pathways For HRT Patches
GPs may require a brief review before switching from patches to an alternative because formulations differ in absorption and side effect profile. A short telephone or video consultation is often enough to authorise a change to gel, spray, or oral therapy when patches are unavailable.
Specialist menopause services can offer longer appointment slots and faster turnaround for patch shortages, particularly if a patient has complex symptoms or needs a regimen change. Requesting a shared care agreement with a menopause specialist can help maintain continuity when primary stock is low.
Alternative Options When Patches Are Unavailable
Many clinicians and patients successfully move to estradiol gel or tablets, especially when the main goal is relief of vasomotor symptoms and vaginal dryness. The transition usually involves a short titration period and monitoring of symptoms and side effects.
- Confirm current dose in mcg or mg when switching forms
- Check for interactions if using other regular medications
- Track symptoms for at least two cycles after changing format
- Ask about local patient advice leaflets and online support groups
Managing Long Term HRT Access And Supply Stability
Planning ahead with a small buffer of patches when they become available, keeping a note of batch numbers, and maintaining open communication with your prescriber can reduce the impact of future shortages.
By combining local pharmacy checks, specialist menopause services, and flexible prescribing, most women can maintain stable symptom control even when specific patch products are temporarily out of stock.
FAQ
Reader questions
Why are oestradiol patches suddenly out of stock in my area?
Manufacturing delays, changes in prescription volumes during the pandemic, and logistics constraints have disrupted the steady supply of oestradiol patches to community pharmacies, with some regions experiencing more severe shortages than others.
Are the shortages affecting combined HRT patches as well, or only oestradiol patches?
Combined patches containing norethisterone are also affected, often more severely, because they share similar supply lines and are used by a smaller patient group, making restocking less predictable for wholesalers.
Can my GP prescribe an alternative form of HRT if patches are not available?
Yes, GPs can prescribe oestradiol gel, tablets, or other non-patch formulations, and in many cases they will do so after a brief review to ensure the new method matches your symptoms and medical history.
What should I do if my repeat prescription for HRT patches was suddenly rejected due to stock issues?
Contact your GP surgery to request a short-term alternative, check with a specialist menopause clinic for faster options, and consider collecting from a different pharmacy that may have received a fresh delivery.